| ZFIN ID: ZDB-EXP-240408-8 |
Experiment Conditions Description: hypoxia, chemical treatment by environment: chloroquine, chemical treatment by environment: N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal
| hypoxia |
|---|
| Name: | hypoxia |
|---|---|
| Synonyms: | |
| Definition: | An oxygen content with low concentration of oxygen. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000189] |
| chemical treatment by environment: chloroquine |
|---|
| Name: | chemical treatment by environment |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
| Name: | chloroquine |
|---|---|
| Synonyms: | Aralen, Artrichin, Bemaphate, Capquin, Chlorochin, Chloroquine, chloroquinum, cloroquina, N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine, N(4)-(7-chloroquinolin-4-yl)-N(1),N(1)-diethylpentane-1,4-diamine, Nivaquine B, Resoquine, Reumachlor, Sanoquin |
| Definition: | An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis. |
| Ontology: | ChEBI [CHEBI:3638] ( EBI ) |
| chemical treatment by environment: N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal |
|---|
| Name: | chemical treatment by environment |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
| Name: | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal |
|---|---|
| Synonyms: | (S)-N-((phenylmethoxy)carbonyl)-L-leucyl-N-(1-formyl-3-methylbutyl)-L-leucinamide, benzyloxycarbonyl-leu-leu-leu-aldehyde, benzyloxycarbonyl-leucyl-leucyl-leucinal, benzyloxycarbonylleucyl-leucyl-leucine aldehyde, carbobenzoxy-Leu-Leu-leucinal, carbobenzoxy-leucyl-leucyl-leucinal, carbobenzoxyl-leucinyl-leucinyl-leucinal-H, Cbz-L-Leu-L-Leu-L-Leu-CHO, Cbz-L-Leu-L-Leu-L-Leu-H, Cbz-Leu-Leu-Leu-CHO, Cbz-Leu-Leu-Leu-H, Cbz-Leu-Leu-Leucinal, MG 132, MG-132, N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide, Z-Leu-Leu-Leu-al, Z-Leu-Leu-Leu-CHO, Z-Leu-Leu-Leu-H, Z-Leu-Leu-Leucinal, Z-LLL-CHO, Z-LLL-H, Z-LLLal, ZLLL-CHO, ZLLLal |
| Definition: | A tripeptide that is L-leucyl-L-leucyl-L-leucine in which the C-terminal carboxy group has been reduced to the corresponding aldehyde and the N-terminal amino group is protected as its benzyloxycarbonyl derivative. |
| Ontology: | ChEBI [CHEBI:75142] ( EBI ) |
| Publication: | Park et al., 2022 |
|---|